Agent Medical launched ArthroBridgeâ„¢, an implant for the treatment of hammertoes, and the ArthroMateâ„¢ rasp designed for rear foot fusion procedures.
Bone Therapeutics was granted an additional 2MM (~US $2.15MM) in non-dilutive funding, bringing the total non-dilutive funding received within 2015 to 5MM.
Smith+Nephew completed its acquisition of Blue Belt Technologies, developer of the Navio surgical robotics-assistance system for unicondylar knee replacement.
Ortho Kinematics closed US $4MM in debt financing. Funds will support global commercialization of the Vertebral Motion Analysis product for radiographic assessment of spinal motion and instability, as well as launch of new product features.
Vericel submitted a Biologics License Application to FDA for MACIâ„¢ matrix applied characterized autologous cultured chondrocytes, an investigational product intended to treat adult symptomatic cartilage defects of the knee.
The extremities market generated worldwide product sales of $6.7 billion in 2014, a 9.5% year-over-year increase driven by the absence of payor scrutiny and company saturation, as well as heightened interest from surgeons and patients, according to ORTHOWORLD estimates.